LOXO-783
N/A
Report date: 2026/04/21 20:00:18
NME
Base Information
Drug NameLOXO-783
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLoxo Oncology Inc
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyLoxo Oncology Inc
Inactive CompaniesSerán BioScience LLCLilly Suzhou Pharmaceutical Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A